Metformin in the management of patients with diabetes and advanced heart failure (HFrEF): a propensity score-matched analysis
Jan Beneš(Institute of Clinical and Experimental Medicine), Vojtěch Melenovský(Institute for Environmental Policy)
Cited by 0
Related Papers
Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
|New England Journal of Medicine|2024|693
Baseline Characteristics of Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction: The FINEARTS-HF Trial
|European Journal of Heart Failure|2024|62
Metformin treatment is associated with improved outcome in patients with diabetes and advanced heart failure (HFrEF)
|Scientific Reports|2022|29
Metformin treatment is associated with improved outcome in patients with diabetes and advanced heart failure (HFrEF)
|Zenodo (CERN European Organization for Nuclear Research)|2022|0